Nautilus Biotechnology, Inc. (NAUT) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Current Price
$2.62
Price Target
$2.50
Target Range
$2.50 — $2.50
Analyst Rating
Buy
Forward P/E—
Trailing P/E-5.6x
Forward PEG—
Implied Growth-10.5%
Median Target$2.50
Analyst Spread0.0%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$3
-4.6%
Consensus
$3
-4.6%
Bull Case
$3
-4.6%
NAUT Price Target Analysis
Updated March 5, 2026As of March 5, 2026, Nautilus Biotechnology, Inc. (NAUT) has a Wall Street consensus price target of $2.50, based on estimates from 5 covering analysts. With the stock currently trading at $2.62, this represents a potential downside of -4.6%. The company has a market capitalization of $331M.
Analyst price targets range from a low of $2.50 to a high of $2.50, representing a 0% spread in expectations. The median target of $2.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 3 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, NAUT trades at a trailing P/E of -5.6x. Analysts expect EPS to grow -10.5% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+40.9%
Avg Forward P/E42.0x
Peers with Coverage5 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
| NAUTNautilus Biotechnology, Inc. | $331M | $2.62 | $2.50 | -4.6% | Buy | — | 5 |
 CAICaris Life Sciences, Inc. | $33.2B | $19.86 | $31.33 | +57.8% | Buy | 62.1x | 6 |
 VCYTVeracyte, Inc. | $2.9B | $36.27 | $47.25 | +30.3% | Buy | 22.0x | 20 |
 ADPTAdaptive Biotechnologies Corporation | $2.5B | $16.44 | $21.25 | +29.3% | Buy | — | 17 |
 CDIOCardio Diagnostics Holdings, Inc. | $141M | $5.26 | — | — | — | — | — |
 SEERSeer, Inc. | $103M | $1.85 | — | — | Hold | — | 4 |
 IMDXInsight Molecular Diagnostics Inc. | $95M | $5.47 | $10.50 | +92.0% | Buy | — | 11 |
 ASBPAspire Biopharma Holdings, Inc. | $63M | $1.32 | — | — | — | — | — |
 YDESYD Bio Limited Ordinary Shares | $35M | $8.45 | — | — | — | — | — |
 AIMDAinos, Inc. | $7M | $1.51 | — | — | — | — | — |
Upside Potential Comparison
IMDXCAIVCYTADPTNAUTSee NAUT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NAUT Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare NAUT vs LLY
See how NAUT stacks up against sector leader Eli Lilly and Company.
Start ComparisonFrequently Asked Questions
What is the NAUT stock price target for 2026?
Wall Street's consensus price target for NAUT is $2.5, -4.6% from its current price of $2.62. The below-market target from 5 analysts suggests limited near-term appreciation.
Is NAUT a buy, sell, or hold?
NAUT has a consensus rating of "Buy" based on 5 Wall Street analysts. The rating breakdown is predominantly bullish, with 3 Buy/Strong Buy ratings. The consensus 12-month price target of $2.5 implies -4.6% downside from current levels.
Is NAUT stock overvalued or undervalued?
NAUT's current price is $2.62 with a consensus target of $2.5 (-4.6% implied move). Analyst estimates suggest the stock is fairly valued at current levels.
How high can NAUT stock go?
The most bullish Wall Street analyst has a price target of $2.5 for NAUT, while the most conservative target is $2.5. The consensus of $2.5 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover NAUT stock?
NAUT is moderately covered, with 5 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 1 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the NAUT stock forecast?
The 12-month NAUT stock forecast based on 5 Wall Street analysts shows a consensus price target of $2.5, with estimates ranging from $2.5 (bear case) to $2.5 (bull case). The median consensus rating is "Buy".
Should I buy NAUT stock?
Analysts are cautious on NAUT, with 1 Sell ratings and a price target of $2.5 (-4.6% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do NAUT price targets vary so much?
NAUT analyst price targets range from $2.5 to $2.5, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $2.5 consensus represents the middle ground.